UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
July 24, 2017
____________________________
ChineseInvestors.com, Inc.
(Exact name of registrant as specified in its charter)
____________________________
| Indiana | 000-54207 | 35-2089868 |
| (State of Organization) | (Commission File Number) | (I.R.S. Employer Identification Number) |
| 227 W. Valley Blvd. #208A, San Gabriel, CA | 91776 |
| (Address of principal executive offices) | (Zip Code) |
(800) 808-8760
(Registrant’s telephone number, including area code)
Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfying the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 - Other Events
ChineseInvestors.com,, Inc. has issued a new press release disclosing the Company’s introduction of its new line of non-industrial hemp infused skin care products, the “CBD Magic Hemp Series” and the filing with the China Food and Drug Administration for authorization to sell the CBD Magic Hemp Series skin care products in China.
Item 9.01 - Financial Statements and Exhibits
(d) Exhibits
| 99.1 | Copy of press release that the Company issued on July 24, 2017 describing its first line of non-industrial hemp infused skin care products, the “CBD Magic Hemp Series.” |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: July 24, 2017
ChineseInvestors.com, Inc.
By: /s/ Wei Wang
Name: Wei Wang
Title: Chief Executive Officer
Exhibit 99.1
ChineseInvestors.com, Inc.’s Subsidiary Files Record of its First Hemp-Infused Skin Care Line with China FDA
SAN GABRIEL, CA (July 24, 2017) - ChineseInvestors.com, Inc. (OTCQB: CIIX) (“CIIX” or the “Company”), the premier financial information website for Chinese-speaking investors, today announces that its wholly owned foreign enterprise, CBD Biotechnology Co. Ltd., has officially filed a record of its first line of non-industrial hemp-infused skin care products with the China Food and Drug Administration (CFDA). The new “CBD Magic Hemp Series” skin care line is expected to launch between late August and early September 2017, positioning CBD Biotechnology as a first-mover in an untapped segment of China’s skin care industry.
CBD (cannabidiol) is a non-psychoactive cannabis compound. Although ancient Chinese recognized the medicinal properties of the cannabis plant, CBD extract appears to be largely unrecognized in China today for its benefits, including but not limited to, its potential benefits to the largest visible human organ, the skin. The effects of increased air pollution on the human body are a growing concern for many in China. With regard to our skin, toxins in air pollution promote the production of free radicals, causing premature aging including coarse wrinkles and dark spots. However, some dermatologists believe that the anti-oxidants and anti-inflammatory agents in CBD can potentially have anti-aging effects on the skin.
Recognizing the untapped market potential, CBD Biotechnology is developing and manufacturing what it believes to be the first line of non-industrial hemp-infused skin care products in China in hopes of educating the Chinese population on the potential benefits of CBD for skin care.
“I am very pleased to announce the upcoming launch of CBD Biotechnology’s non-industrial hemp-infused skin care line,” says Summer Yun, CEO of CBD Biotechnology Co., Ltd. “As one of the first skin care products containing CBD extract marketed in China, CBD Magic Hemp Series expects to capture up to 100% of China’s market share in this novel skin care products category. Although a catalogue published by the CFDA, indicates that cannabis sativa leaf extract can legally be added to skin care products, it appears that Chinese skin care manufacturers have not yet entered this market, enabling CBD Biotechnology’s skin care products to proudly take the lead with its innovative product line.”
The “CBD Magic Hemp Series” will include:
| · | The CBD Peptide Collagen Solution – intended to moisturize and firm the skin, while smoothing fine lines, and preventing premature aging; |
| · | The CBD Perfecting Shield Primer – intended to even skin tone, while covering fine lines and minimizing the look of pores; and |
| · | The CBD Brightening and Refreshing Moisturizer - intended to balance the skin’s moisture, while forming a protective, moisturizing layer. |
“Consumption of skin care products per capita in China has increased from 169 Chinese Yuan Renminbi (“CNY”) to 352CNY during the last five years,” says Yun. “China has the world’s second largest consumer market for skin care products, with its current market size already exceeding 300 billion CNY. The CARG (compound annual growth rate) of the skin care products market in China is 9.1%, more than double the global average of 4.1%. CBD Biotechnology will benefit from this large consumer market in China becoming one of the first companies in China to infuse its skin care products CBD extracted from non-industrial hemp”
About ChineseInvestors.com (OTCQB: CIIX)
Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail, online sales and direct sales of non-industrial hemp-based products and other health related products.
For more information visit ChineseInvestors.com
Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom
Follow us on Twitter for real-time Company updates: https://twitter.com/ChineseFNEnglsh
Like us on Facebook to receive live feeds: https://www.facebook.com/Chinesefncom;
https://www.facebook.com/Chineseinvestors.com.english
Add us on WeChat: Chinesefn or download iPhone iOS App: Chinesefn.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Contact:
ChineseInvestors.com, Inc.
227 W. Valley Blvd, #208 A
San Gabriel, CA 91776
Investor Relations:
Alan Klitenic
+1.214.636.2548
Corporate Communications:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com